The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, manufacturer Abbott announced in a press release. The Proclaim XR spinal cord stimulation (SCS) system can provide relief to patients with diabetic peripheral neuropathy (DPN) in need of alternatives to traditional approaches, such as oral medication.